PADI2 Recombinant Rabbit Monoclonal Antibody [PSH18-06]
cat.: HA723969
Product Type: Recombinant Rabbit monoclonal IgG, primary antibodies
Species reactivity: Human
Applications: WB, IHC-P, IP
Clonality: Monoclonal
Clone number: PSH18-06
Form: Liquid
Storage condition: Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage buffer: 1*PBS (pH7.4), 0.1% BSA, 40% Glycerol, 0.2% Proclean 950.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 76 kDa
Isotype: IgG
Immunogen: Recombinant protein within human PADI2 aa 1-350.
Positive control: PANC-1 cell lysate, SK-Br-3 cell lysate, MCF7 cell lysate, HT-29 cell lysate, human breast cancer tissue, human colon tissue.
Subcellular location: Cytoplasm.
Recommended Dilutions:
  WB
  IHC-P
  IP

1:5,000
1:200-1:1,000
1-2μg/sample
Uniprot #: SwissProt: Q9Y2J8 Human
Alternative names: KIAA0994 OTTHUMP00000044625 PAD 2 PAD H19 PAD-H19 PAD2 PADI 2 Padi2 PADI2 protein PADI2_HUMAN PDI 2 PDI2 Peptidlyarginine deiminase type II Peptidyl arginine deiminase II Peptidyl arginine deiminase type II Peptidylarginine deiminase II Protein arginine deiminase Protein arginine deiminase type 2 Protein arginine deiminase type II Protein-arginine deiminase type II Protein-arginine deiminase type-2
Images
HA723969_1.jpg Fig1: Western blot analysis of PADI2 on different lysates with Rabbit anti-PADI2 antibody (HA723969) at 1/5,000 dilution.

Lane 1: PANC-1 cell lysate (20 µg/Lane)
Lane 2: SK-Br-3 cell lysate (20 µg/Lane)
Lane 3: MCF7 cell lysate (low expression) (20 µg/Lane)
Lane 4: HT-29 cell lysate (20 µg/Lane)

Predicted band size: 76 kDa
Observed band size: 75 kDa

Exposure time: Lane 1-2: 6 seconds; Lane 3-5: 3 minutes; ECL: K1801;
4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723969) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
HA723969_2.jpg Fig2: Immunohistochemical analysis of paraffin-embedded human breast cancer tissue with Rabbit anti-PADI2 antibody (HA723969) at 1/200 dilution.

The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA723969) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
HA723969_3.jpg Fig3: Immunohistochemical analysis of paraffin-embedded human colon tissue with Rabbit anti-PADI2 antibody (HA723969) at 1/1,000 dilution.

The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (HA723969) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
HA723969_4.jpg Fig4: PADI2 was immunoprecipitated from 0.2 mg PANC-1 cell lysate with HA723969 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using HA723969 at 1/5,000 dilution. HRP Conjugated Anti-Rabbit IgG for IP Nano-secondary antibody at 1/5,000 dilution was used for 1 hour at room temperature.

Lane 1: PANC-1 cell lysate (input)
Lane 2: HA723969 IP in PANC-1 cell lysate
Lane 3: Rabbit IgG instead of HA723969 in PANC-1 cell lysate

Blocking/Dilution buffer: primary antibody dilution (K1803)
Exposure time: 2 seconds; ECL: K1801
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.